Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Radius Health stock in Canada | $19.29

Own Radius Health shares in just a few minutes.

Radius Health, Inc
NASDAQ: RDUS - USD
DRUG MANUFACTURERS-SPECIALTY & GENERIC
$15.04
-$0.09 (-0.59%)

Radius Health is a drug manufacturers-specialty & generic business based in the US. Radius Health stocks (RDUS.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $17.54 – a decrease of 1.93% over the previous week. Radius Health employs 310 staff and has a trailing 12-month revenue of around $247 million.

How to buy Radius Health stock in Canada

  1. Choose a platform. If you're a beginner, our stock trading table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: RDUS in this case.
  5. Research Radius Health stocks. The platform should provide the latest information available.
  6. Buy your Radius Health stocks. It's that simple.

How has Coronavirus impacted Radius Health's stock price?

Since the stock market crash in March caused by coronavirus, Radius Health's stock price has had significant negative movement.

Its last market close was $19.29, which is 0.36% down on its pre-crash value of $19.36 and 86.92% up on the lowest point reached during the March crash when the stocks fell as low as $10.32.

If you had bought $1,000 worth of Radius Health stocks at the start of February 2020, those stocks would have been worth $588.67 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $972.22.

Radius Health stock price

Use our graph to track the performance of RDUS stocks over time.

Radius Health stocks at a glance

Information last updated 2021-07-28.
Latest market close$19.29
52-week range$10.1511 - $25.82
50-day moving average $17.9466
200-day moving average $20.0046
Wall St. target price$24.57
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.7

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Available Asset Types Stock Fee Option Fee Account Fee ETF Transaction Cost Feature Table description
OFFER
Wealthsimple Trade
Stocks, ETFs
$0
N/A
$0
Free
Get a $50 bonus when you open a Wealthsimple Trade account and deposit and trade at least $100.
Pay no commissions when you trade Canadian stocks and ETFs with Wealthsimple Trade.
Scotia iTRADE
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
$4.99-$9.99
$9.99 + $1.25 contract ($4.99 + $1.25 contract if completed 150 trades or more a quarter)
$0
$9.99 ($4.99 if completed 150 trades or more a quarter)
Pay no annual account fees.
Buy, sell and trade ETFs, Equities, Options and more with competitive commissions.
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95 - $6.95
$4.95 - $6.95 (+$1.25 per contract)
$0 if conditions met, otherwise $100/year
$6.95
$4.95 - $6.95 is applicable for online stock, ETF and option trades only. Pay $4.95 when you qualify as an Active Trader (trade 150+ times per quarter).
An intuitive and easy-to-use platform with access to a variety of tools that help you make smart decisions and trade with confidence.
Interactive Brokers
Stocks, Bonds, Options, ETFs, Currencies, Futures
Min. $1.00, Max. 0.5% of trade value
$1.50 min. per order
$0
Min. $1.00, Max. 0.5% of trade value
Extensive trading capabilities and global investment tracking.
Access market data 24 hours a day, six days a week and invest in global stocks, options, futures, currencies, bonds and funds from one single account.
Questrade
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95-$9.95
$9.95 + $1 per contract
$0
Free
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio and take some of the guesswork out.
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$6.95 - $8.75 + $1.25 per contract
$0 if conditions met, otherwise $25/quarter
$0 - $8.75
Trade 100 select ETFs free of charge.
Qtrade Direct Investing offers low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options. Trade 100 ETFs free of charge and thousands more for $8.75 or lower.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy Radius Health stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Radius Health price performance over time

Historical closes compared with the last close of $19.29

1 month (2021-07-02) 8.07%
3 months (2021-04-30) -13.50%

Radius Health financials

Revenue TTM USD$247 million
Gross profit TTM USD$222.2 million
Return on assets TTM -19.75%
Return on equity TTM 0%
Profit margin -35.35%
Book value $-0.003
Market capitalisation USD$748.3 million

TTM: trailing 12 months

How to short and sell Radius Health stocks

  1. Create a CFD or spread betting account.
  2. Search for the stock code. E.g. "RDUS.US"
  3. Choose your position size.
  4. Select "sell" rather than "buy".
  5. Confirm your position and keep tabs on it. You may wish to set limits on your position.

There are currently 5.0 million Radius Health stocks held short by investors – that's known as Radius Health's "short interest". This figure is 3.5% down from 5.1 million last month.

There are a few different ways that this level of interest in shorting Radius Health stocks can be evaluated.

Radius Health's "short interest ratio" (SIR)

Radius Health's "short interest ratio" (SIR) is the quantity of Radius Health stocks currently shorted divided by the average quantity of Radius Health stocks traded daily (recently around 289986.81898067). Radius Health's SIR currently stands at 17.07. In other words for every 100,000 Radius Health stocks traded daily on the market, roughly 17070 stocks are currently held short.

However Radius Health's short interest can also be evaluated against the total number of Radius Health stocks, or, against the total number of tradable Radius Health stocks (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Radius Health's short interest could be expressed as 0.1% of the outstanding stocks (for every 100,000 Radius Health stocks in existence, roughly 100 stocks are currently held short) or 0.1059% of the tradable stocks (for every 100,000 tradable Radius Health stocks, roughly 106 stocks are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the stock price and a discouraging interest in betting against Radius Health.

Find out more about how you can short Radius Health stock.

Radius Health stock dividends

We're not expecting Radius Health to pay a dividend over the next 12 months. However, you can browse other dividend-paying stocks in our guide.

Have Radius Health stocks ever split?

Radius Health stocks were split on a 1:2 basis on 24 April 2014. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Radius Health stocks – just the quantity. However, indirectly, the new 100% higher stock price could have impacted the market appetite for Radius Health stocks which in turn could have impacted Radius Health's stock price.

Radius Health stock price volatility

Over the last 12 months, Radius Health's stocks have ranged in value from as little as $10.1511 up to $25.82. A popular way to gauge a stock's volatility is its "beta".

RDUS.US volatility(beta: 0.97)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Radius Health's is 0.9733. This would suggest that Radius Health's stocks are less volatile than average (for this exchange).

Radius Health overview

Radius Health, Inc., a biopharmaceutical company, develops and commercializes endocrine and other therapeutics. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a short-wear-time transdermal patch that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone receptor-positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts.

Stocks similar to Radius Health

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site